Literature DB >> 24435047

Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.

Hongxiu Li1, Mark S Kaminski, Yifeng Li, Mehmet Yildiz, Peter Ouillette, Siân Jones, Heather Fox, Kathryn Jacobi, Kamlai Saiya-Cork, Dale Bixby, Daniel Lebovic, Diane Roulston, Kerby Shedden, Michael Sabel, Lawrence Marentette, Vincent Cimmino, Alfred E Chang, Sami N Malek.   

Abstract

Follicular lymphoma (FL) constitutes the second most common non-Hodgkin lymphoma in the western world. FL carries characteristic recurrent structural genomic aberrations. However, information regarding the coding genome in FL is still evolving. Here, we describe the results of massively parallel exome sequencing and single nucleotide polymorphism 6.0 array genomic profiling of 11 highly purified FL cases, and 1 transformed FL case and the validation of selected mutations in 102 FL cases. We report the identification of 15 novel recurrently mutated genes in FL. These include frequent mutations in the linker histone genes HIST1H1 B-E (27%) and mutations in OCT2 (also known as POU2F2; 8%), IRF8 (6%), and ARID1A (11%). A subset of the mutations in HIST1H1 B-E affected binding to DNMT3B, and mutations in HIST1H1 B-E and in EZH2 or ARID1A were largely mutually exclusive, implicating HIST1H1 B-E in epigenetic deregulation in FL. Mutations in OCT2 (POU2F2) affected its transcriptional and functional properties as measured through luciferase assays, the biological analysis of stably transduced cell lines, and global expression profiling. Finally, multiple novel mutated genes located within regions of acquired uniparental disomy in FL are identified. In aggregate, these data substantially broaden our understanding of the genomic pathogenesis of FL.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24435047      PMCID: PMC4729540          DOI: 10.1182/blood-2013-05-500264

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  57 in total

1.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

2.  Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation.

Authors:  Yuhong Fan; Tatiana Nikitina; Jie Zhao; Tomara J Fleury; Riddhi Bhattacharyya; Eric E Bouhassira; Arnold Stein; Christopher L Woodcock; Arthur I Skoultchi
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

3.  Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18).

Authors:  D E Horsman; J M Connors; T Pantzar; R D Gascoyne
Journal:  Genes Chromosomes Cancer       Date:  2001-04       Impact factor: 5.006

4.  Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.

Authors:  C A Heckman; H Duan; P B Garcia; L M Boxer
Journal:  Oncogene       Date:  2006-02-09       Impact factor: 9.867

5.  B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1.

Authors:  K Schubart; S Massa; D Schubart; L M Corcoran; A G Rolink; P Matthias
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

Review 6.  Molecular pathways in follicular lymphoma.

Authors:  R J Bende; L A Smit; C J M van Noesel
Journal:  Leukemia       Date:  2006-10-12       Impact factor: 11.528

7.  Clinicopathologic correlations of genomic gains and losses in follicular lymphoma.

Authors:  Andreas Viardot; Peter Möller; Josef Högel; Kirsten Werner; Gunhild Mechtersheimer; Anthony D Ho; German Ott; Thomas F E Barth; Reiner Siebert; Stefan Gesk; Brigitte Schlegelberger; Hartmut Döhner; Martin Bentz
Journal:  J Clin Oncol       Date:  2002-12-01       Impact factor: 44.544

8.  Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis.

Authors:  Charles W Ross; Peter D Ouillette; Chris M Saddler; Kerby A Shedden; Sami N Malek
Journal:  Clin Cancer Res       Date:  2007-08-15       Impact factor: 12.531

9.  Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma.

Authors:  J Fitzgibbon; S Iqbal; A Davies; D O'shea; E Carlotti; T Chaplin; J Matthews; M Raghavan; A Norton; T A Lister; B D Young
Journal:  Leukemia       Date:  2007-05-10       Impact factor: 11.528

10.  A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice.

Authors:  Karine Turcotte; Susan Gauthier; Ashleigh Tuite; Alaka Mullick; Danielle Malo; Philippe Gros
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

View more
  77 in total

Review 1.  Epigenetic dysregulation in follicular lymphoma.

Authors:  Shamzah Araf; Jessica Okosun; Lola Koniali; Jude Fitzgibbon; James Heward
Journal:  Epigenomics       Date:  2015-12-23       Impact factor: 4.778

Review 2.  Role of H1 linker histones in mammalian development and stem cell differentiation.

Authors:  Chenyi Pan; Yuhong Fan
Journal:  Biochim Biophys Acta       Date:  2015-12-13

Review 3.  The role of aberrant proteolysis in lymphomagenesis.

Authors:  Anagh A Sahasrabuddhe; Kojo S J Elenitoba-Johnson
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

Review 4.  Epigenetic regulatory mutations and epigenetic therapy for multiple myeloma.

Authors:  Daphné Dupéré-Richer; Jonathan D Licht
Journal:  Curr Opin Hematol       Date:  2017-07       Impact factor: 3.284

5.  Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis.

Authors:  Staci L Haney; Ryan A Hlady; Jana Opavska; David Klinkebiel; Samuel J Pirruccello; Samikshan Dutta; Kaustubh Datta; Melanie A Simpson; Lizhao Wu; Rene Opavsky
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

6.  Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.

Authors:  Kilannin Krysiak; Felicia Gomez; Brian S White; Matthew Matlock; Christopher A Miller; Lee Trani; Catrina C Fronick; Robert S Fulton; Friederike Kreisel; Amanda F Cashen; Kenneth R Carson; Melissa M Berrien-Elliott; Nancy L Bartlett; Malachi Griffith; Obi L Griffith; Todd A Fehniger
Journal:  Blood       Date:  2016-11-14       Impact factor: 22.113

Review 7.  SWI/SNF chromatin remodeling complexes and cancer.

Authors:  Jaclyn A Biegel; Tracy M Busse; Bernard E Weissman
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-08-28       Impact factor: 3.908

8.  Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.

Authors:  Michael Boice; Darin Salloum; Frederic Mourcin; Viraj Sanghvi; Rada Amin; Elisa Oricchio; Man Jiang; Anja Mottok; Nicolas Denis-Lagache; Giovanni Ciriello; Wayne Tam; Julie Teruya-Feldstein; Elisa de Stanchina; Wing C Chan; Sami N Malek; Daisuke Ennishi; Renier J Brentjens; Randy D Gascoyne; Michel Cogné; Karin Tarte; Hans-Guido Wendel
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

9.  Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma.

Authors:  Stephen J Salipante; Andrew Adey; Anju Thomas; Choli Lee; Yajuan J Liu; Akash Kumar; Alexandra P Lewis; David Wu; Jonathan R Fromm; Jay Shendure
Journal:  Genes Chromosomes Cancer       Date:  2015-12-09       Impact factor: 5.006

Review 10.  Epigenetic modulators, modifiers and mediators in cancer aetiology and progression.

Authors:  Andrew P Feinberg; Michael A Koldobskiy; Anita Göndör
Journal:  Nat Rev Genet       Date:  2016-03-14       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.